The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods
Open Access
- 27 June 2011
- journal article
- Published by Springer Science and Business Media LLC in Virology Journal
- Vol. 8 (1), 323
- https://doi.org/10.1186/1743-422x-8-323
Abstract
There have been many efforts to develop efficient vaccines for the control of porcine reproductive and respiratory syndrome virus (PRRSV). Although inactivated PRRSV vaccines are preferred for their safety, they are weak at inducing humoral immune responses and controlling field PRRSV infection, especially when heterologous viruses are involved. In all groups, the sample to positive (S/P) ratio of IDEXX ELISA and the virus neutralization (VN) titer remained negative until challenge. While viremia did not reduce in the vaccinated groups, the IDEXX-ELISA-specific immunoglobulin G increased more rapidly and to significantly greater levels 7 days after the challenge in all the vaccinated groups compared to the non-vaccinated groups (p < 0.05). VN titer was significantly different in the 106 PFU/mL PRRSV vaccine-inoculated and binary ethylenimine (BEI)-inactivated groups 22 days after challenge (p < 0.05). Consequently, the inactivated vaccines tested in this study provided weak memory responses with sequential challenge without any obvious active immune responses in the vaccinated pigs. The inactivated vaccine failed to show the humoral immunity, but it showed different immune response after the challenge compared to mock group. Although the 106 PFU/mL-vaccinated and BEI-inactivated groups showed significantly greater VN titers 22 days after challenge, all the groups were already negative for viremia.Keywords
This publication has 26 references indexed in Scilit:
- Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodiesVeterinary Research, 2009
- Assessing the functionality of viral entry-associated domains of porcine reproductive and respiratory syndrome virus during inactivation procedures, a potential tool to optimize inactivated vaccinesVeterinary Research, 2009
- Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunityVaccine, 2009
- Genetic analysis of ORF5 of recent Korean porcine reproductive and respiratory syndrome viruses (PRRSVs) in viremic sera collected from MLV-vaccinating or non-vaccinating farmsJournal of Veterinary Science, 2009
- Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challengeVeterinary Microbiology, 2007
- Long‐term administration of a commercial porcine reproductive and respiratory syndrome virus (PRRSV)‐inactivated vaccine in PRRSV‐endemically infected sowsJournal of Veterinary Medicine, Series B, 2006
- Inactivation of infectious bursal disease virus by binary ethylenimine and formalinJournal of Zhejiang University-SCIENCE B, 2006
- Examination of virus shedding in semen from vaccinated and from previously infected boars after experimental challenge with porcine reproductive and respiratory syndrome virusVeterinary Microbiology, 1997
- Characterization of Swine Infertility and Respiratory Syndrome (SIRS) Virus (Isolate ATCC VR-2332)Journal of Veterinary Diagnostic Investigation, 1992
- Inactivation of African horse-sickness virus by betapropiolactone and by pHArchiv für die gesamte Virusforschung, 1975